Close Menu

ATLANTA (GenomeWeb) – Treatment with a FLT3 inhibitor improved survival among patients with relapsed or refractory acute myeloid leukemia harboring a FLT3 mutation, according to data presented at the American Association for Cancer Research annual meeting here.

"This is a new practice-changing strategy that is something that we have been needing in the field of acute myelogenous leukemia therapy," Louis Weiner, the director of the Georgetown Lombardi Comprehensive Cancer Center, who was not part of the study, said during a press briefing.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Oct
21

Genomics is a key element in the potential of precision medicine to transform oncology. 

Oct
23

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.